GYRA-NTBI PubChem_15983305 2-oxo-1-[2-[4-[(3-oxo-4H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino]piperidin-1-yl]ethyl]quinoline-7-carbonitrile

TESTED COMPOUNDS 

GYRA-NTBI PubChem_15983305 2-oxo-1-[2-[4-[(3-oxo-4H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino]piperidin-1-yl]ethyl]quinoline-7-carbonitrile

INHIBITORY CONCENTRATION VALUES (MIC/IC50) 

MIC = Inactive

EXPERIMENTAL TECHNIQUE 

in vitro

LINK TO PUBMED 

https://pubmed.ncbi.nlm.nih.gov/32091697/

MOLECULAR FORMULA 

C25H26N6O3

2D STRUCTURE

2D Structure of GYRA-NTBI PubChem_15983305 2-oxo-1-[2-[4-[(3-oxo-4H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino]piperidin-1-yl]ethyl]quinoline-7-carbonitrile

REFERENCE 

Omansen, T. F., van der Werf, T. S., & Phillips, R. O. (2019). Antimicrobial Treatment of Mycobacterium ulcerans Infection. Buruli Ulcer: Mycobacterium ulcerans Disease, 203?220. https://doi.org/10.1007/978-3-030-11114-4_11